Showing results (2371-2380 of 16,225) with videos related to

Sort By:
Pageof 1,623
Journal of Pharmaceutical and Biomedical Analysis|February 17, 2009
Evaluation of non-isothermal methods in stability studies of human insulin pharmaceutical preparationsAlexis Oliva, Marta Suárez, Juan Ramón Hernández, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 17, 2009
Development and characterization of a novel host cell DNA assay using ultra-sensitive fluorescent nucleic acid stain "PicoGreen"Yosuke Ikeda, Shoji Iwakiri, Takayuki Yoshimori
Journal of Pharmaceutical and Biomedical Analysis|February 17, 2009
Simultaneous quantification of losartan and active metabolite in human plasma by liquid chromatography-tandem mass spectrometry using irbesartan as internal standardBudi Prasaja, Lucy Sasongko, Yahdiana Harahap, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 28, 2008
Photostability of pitavastatin--a novel HMG-CoA reductase inhibitorPaweł Grobelny, Giampietro Viola, Daniela Vedaldi, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 8, 2007
Direct determination of metformin in urine by adsorptive catalytic square-wave voltammetrySławomira Skrzypek, Valentin Mirceski, Witold Ciesielski, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 18, 2007
Real-time therapeutic drug monitoring of cefozopran in plasma using high-performance liquid chromatography with ultraviolet detectionKayo Ikeda, Norifumi Morikawa, Misa Kuribayashi, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 19, 2010
Application of LC-NMR and HR-NMR to the characterization of biphenyl impurities in the synthetic route development for vestipitant, a novel NK1 antagonistStefano Provera, Luca Martini, Giuseppe Guercio, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 19, 2010
Correlation of liquid chromatographic and biological assay for potency assessment of filgrastim and related impuritiesAna Skrlin, Ela Kosor Krnic, Darko Gosak, et al.
Pageof 1,623